Loading...
Insulet Corporation
PODD•NASDAQ
HealthcareMedical - Devices
$317.16
$-2.05(-0.64%)
Insulet Corporation (PODD) Financial Performance & Statements
Review Insulet Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
22.07%
↑ 22.07%
Operating Income Growth
40.41%
↑ 40.41%
Net Income Growth
102.76%
↑ 102.76%
Operating Cash Flow Growth
195.33%
↑ 195.33%
Operating Margin
16.81%
↑ 16.81%
Gross Margin
76.50%
↑ 76.50%
Net Profit Margin
19.84%
↑ 19.84%
ROE
34.53%
↑ 34.53%
ROIC
11.37%
↑ 11.37%
Insulet Corporation (PODD) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Insulet Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $597.50M | $372.60M | $488.50M | $441.70M |
| Cost of Revenue | $166.60M | -$4.50M | $154.30M | $131.80M |
| Gross Profit | $430.90M | $377.10M | $334.20M | $309.90M |
| Gross Profit Ratio | $0.72 | $1.01 | $0.68 | $0.70 |
| R&D Expenses | $60.60M | $54.90M | $53.90M | $50.20M |
| SG&A Expenses | $261.00M | $234.10M | $220.00M | $197.30M |
| Operating Expenses | $321.60M | $289.00M | $279.60M | $253.00M |
| Total Costs & Expenses | $488.20M | $284.50M | $433.90M | $384.80M |
| Interest Income | $10.30M | $10.50M | $9.30M | $9.40M |
| Interest Expense | $8.70M | $12.30M | $11.00M | $10.70M |
| Depreciation & Amortization | $21.50M | $21.30M | $19.20M | $18.80M |
| EBITDA | $141.50M | $116.50M | $81.30M | $103.90M |
| EBITDA Ratio | $0.24 | $0.31 | $0.17 | $0.24 |
| Operating Income | $109.30M | $88.10M | $54.60M | $56.90M |
| Operating Income Ratio | $0.18 | $0.24 | $0.11 | $0.13 |
| Other Income/Expenses (Net) | $2.00M | -$5.20M | -$3.50M | -$2.00M |
| Income Before Tax | $111.30M | $82.90M | $51.10M | $54.90M |
| Income Before Tax Ratio | $0.19 | $0.22 | $0.10 | $0.12 |
| Income Tax Expense | $10.60M | $5.40M | -$137.50M | $3.40M |
| Net Income | $100.70M | $77.50M | $188.60M | $51.50M |
| Net Income Ratio | $0.17 | $0.21 | $0.39 | $0.12 |
| EPS | $1.44 | $1.14 | $2.73 | $0.74 |
| Diluted EPS | $1.39 | $1.08 | $2.59 | $0.73 |
| Weighted Avg Shares Outstanding | $70.16M | $70.12M | $70.06M | $69.96M |
| Weighted Avg Shares Outstanding (Diluted) | $74.08M | $73.95M | $73.80M | $73.74M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan